This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Yet, the R&D process for drug discovery relies on 2D monitors, keyboard, and mouse, which limits the understanding of complex 3D structures or interactions and contributes to massive R&D costs averaging $2.5B “Understanding structure empowers our users to understand how their designs function,” he wrote in an email. per drug.”.
Andiamo uses machine learning, 3D simulation and 3D printing to create custome braces for children with cerebral palsy, bringing down the cost and improving outcomes for clinicians, patients and families alike. So without any further ado, here are the startups graduating out of the summer 2021 ERA class. departments.
Healthcare/biotech companies took the lead with three companies that joined the board from this sector. VR AR Infinite Reality , a creator of 3D immersive environments, raised a $350 million funding at a $5.1 Its customers include academia, biotech, cancer research and agriculture according to the announcement.
The investment scene is described variously as focusing on software, clean tech, life sciences, biotech, organoids, 3D bioprinting, AI and VR/AR. A lot of focus is on life sciences, biotech, as there is a lot of research at the Utrecht science park and also spin-offs. One says: “In Amsterdam it’s ok.
After 2 months in an underground shelter they have also used their technology to register evidence of war crimes and provide the ability to immerse oneself into Ukraine to experience it, it’s now developing applications for psychological trauma treatment, VR medical trainin, combat surveillance systems and making the de-mining process safer.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content